The Use of Femoropopliteal Stent-Grafts for Critical Limb Ischemia

Techniques in Vascular and Interventional Radiology

Volumn 8, Issue 4, 2005, Pages 140-145

  Ansel, Gary M ^a   Botti Jr , Charles F ^a   Silver, Mitchel J ^a  

^a RIVERSIDE METHODIST HOSPITAL   (United States)

Author keywords

angioplasty; arterial; femoropopliteal; stent; stent graft

Indexed keywords

ARTICLE; ATHERECTOMY; CARDIOVASCULAR RISK; CLINICAL FEATURE; ENDOVASCULAR SURGERY; EVALUATION; FEMORAL ARTERY; FEMOROPOPLITEAL BYPASS; HIGH RISK POPULATION; HUMAN; LASER; LIMB ISCHEMIA; MORTALITY; POPLITEAL ARTERY; RISK ASSESSMENT; TREATMENT OUTCOME;

ANGIOGRAPHY; ARTERIAL OCCLUSIVE DISEASES; BLOOD VESSEL PROSTHESIS; FEMORAL ARTERY; HUMANS; ISCHEMIA; LEG; PERIPHERAL VASCULAR DISEASES; POPLITEAL ARTERY; STENTS;

EID: 33745868374     PISSN: 10892516     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.tvir.2006.04.002     Document Type: Article

References (49)

1. Adar R., Critchfield G.C., and Eddy D.M. A confidence profile analysis of the results of fempop percutaneous transluminal angioplasty in the treatment of lower extremity ischemia. J Vasc Surg 10 (1989) 57-67
2. Hunink M.G., Wong J.B., Donaldson M.C., et al. Patency results of percutaneous and surgical revascularizations for femoropopliteal arterial disease. Med Decis Making 14 (1994) 71-81
3. Adam D.J., Beard J.D., Cleveland T., et al. BASIL trial participants. Bypass versus angioplasty in severe ischemia of the leg (BASIL). multicenter, randomized controlled trial. Lancet 366 (2005) 1925-1934
4. Johnson K.W. Femoral and popliteal arteries. reanalysis of results of balloon angioplasty. Radiology 183 (1992) 767-771
5. Gray B.H., and Olin J.W. Limitations of percutaneous angioplasty and stenting for femoropopliteal arterial occlusive disease. Semin Vasc Surg 10 (1997) 8-16
6. FDA Intracoil data. Food and Drug Administration. Cardiovascular and Radiologic Health Advisory Board. 2001;April 23
7. Waksman R. Paris. brachytherapy IR192 offers no benefit. http://www.tctmd.comm/csportal/appmanager/tctmd/main?_nfpb=true&_pageLabel=TCTMDContent&hdCon=92079
8. Cejna M., Thurnher S., Illiasch H., et al. PTA versus Palmaz stent placement in femoropopliteal artery obstructions. a multicenter prospective randomized study. J Vasc Interv Radiol 12 (2001) 23-31
9. Pokrajac B., Potter R., Roswitha M., et al. Endovascular brachytherapy prevents restenosis after femoropopliteal angioplasty. results of the Vienna-3 randomized multicenter trial. Radiother Oncol 74 (2005) 3-9
10. Laird J. Laser applications in the periphery. http://tctmc.com/csportal/appmanager/tctmd/main?_nfpb=true&pageLabel=TCTMDContent&hdCon=836311
11. Laird J., Jaff M.R., Biamino G., et al. Cryoplasty for the treatment of femoropopliteal arterial disease. results of a prospective, multicenter registry. J Vasc Interv Radiol 16 (2005) 1067-1073
12. Scheinert D., Laird J., Schroeder M., et al. Excimer laser-assisted recanalization of long, chronic superficial femoral artery occlusions. J Endovasc Ther 8 (2001) 156-166
13. Tielbeek A.V., Vroegindeweij D., Buth J., et al. Comparison of balloon angioplasty and Simpson atherectomy for lesions in the femoropopliteal artery. angiographic and clinical results of a prospective randomized trial. J Vasc Interv Radiol 7 (1996) 837-844
14. Zeller T., Rastan A., Schwarzwalder U., et al. Percutaneous peripheral atherectomy of femoropopliteal stenoses using a new-generation device. six-month results from a single-center experience. J Endovasc Ther 11 (2004) 676-685
15. Martin E.C., Katzen B.T., Benenati J.F., et al. Multicenter trial of the wallstent in the iliac and femoral arteries. J Vasc Interv Radiol 6 (1995) 843-849
16. Gray B.H., Sullivan T.M., Childs M.B., et al. High incidence of restenosis/reocclusion of stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal angioplasty. J Vasc Surg 25 (1997) 74-83
17. Sabeti S., Schillinger M., Amighi J., et al. Primary patency of femoropopliteal arteries treated with nitinol versus stainless steel self-expanding stents. propensity score-adjusted analysis. Radiology 232 (2004) 516-521
18. Ansel G.M., Silver M.J., Botti Jr. C.F., et al. Functional and clinical outcomes of nitinol stenting with and without abciximab for complex superficial femoral artery disease. a randomized trial. Catheter Cardiovasc Interv (2006) (in press)
19. Scheinert D. Nitinol stent fractures in different nitinol self-expanding stents. a prospective evaluation. http://www.tctmd.com/csportal/appmanager/tctmd/main?_nfpb=true&_pageLabel=TCTMDContent&hdCon=808868
20. Scheinert D., Scheinert S., Sax J., et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. Am Coll Cardiol 45 (2005) 312-315
21. Mewissen M.W. Self-expanding nitinol stents in the femoropopliteal segment. technique and mid-term results. Tech Vasc Interv Radiol 7 (2004) 2-5
22. Duda S.H., Pusich B., Richter G., et al. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease. six-month results. Circulation 106 (2002) 1505-1509
23. Cragg A.H., and Dake M.D. Treatment of peripheral vascular disease with stent-grafts. Radiology 205 (1997) 307-314
24. Henry M., Amor M., Cragg A., et al. Occlusive and aneurysmal peripheral arterial disease. assessment of a stent-graft system. Radiology 201 (1996) 717-724
25. Ahmadi R., Schillinger M., Maca T., et al. Femoropopliteal arteries. immediate and long-term results with a Dacron-covered stent-graft. Radiology 223 (2002) 345-350
26. Marin J., Veith F., Cynamon J., et al. Human transluminal placed endovascular stented grafts. preliminary histopathologic analysis of healing grafts in aortoiliac and femoral artery occlusive disease. J Vasc Surg 21 (1995) 595-604
27. Lammer J., Dake M.D., Bleyn J., et al., International Trial Study Group. Peripheral arterial obstruction. prospective study of treatment with a transluminally placed self-expanding stent-graft. Radiology 217 1 (2000) 95-104
28. Jahnke T., Andresen R., Muller-Hulsbeck S., et al. Hemobahn stent-grafts for treatment of femoropopliteal arterial obstructions. midterm results of a prospective trial. J Vasc Interv Radiol 14 1 (2003) 41-51
29. Saxon R.R., Coffman J.M., Gooding J.M., et al. Stent-graft use in the femoral and popliteal arteries. Tech Intervent Vasc Radiol 7 (2004) 6-15
30. Turicchia G.U., Cevolani M., Altini R., et al. Mid-term results in PTFE endograft treatment of femoropopliteal occlusive disease. Osp Ital Chir 9 (2003) 93-96
31. Deutschmann H.A., Schedlbauer P., Berczi V., et al. Placement of Hemobahn stent-grafts in femoropopliteal arteries. early experience and midterm results in 18 patients. J Vasc Interv Radiol 12 8 (2001) 943-950
32. Bray P.J., Robson W.J., and Bray A.E. Percutaneous treatment of long superficial femoral artery occlusive disease. efficacy of the Hemobahn stent-graft. J Endovasc Ther 10 3 (2003) 619-628
33. Daenens K., Maleux G., Fourneau I., et al. Hemobahn stent-grafts in the treatment of femoropopliteal occlusive disease. J Cardiovasc Surg 46 (2005) 25-29
34. Fischer M., Langhoff R., and Schulte K.L. Hemobahn-endoprosthesis. long term experience (< or = 4 years follow up) with percutaneous application in stenoses and occlusions of the superficial femoral artery. Zentralbl Chir 128 (2003) 740-745
35. Railo M., Roth W.D., Edgren J., et al. Preliminary results with endoluminal femoropopliteal thrupass. Ann Chir Gynaecol 90 1 (2001) 15-18
36. Bauermeister G. Endovascular stent-grafting in the treatment of superficial femoral artery occlusive disease. J Endovasc Ther 8 3 (2001) 315-320
37. Hartung O., Otero M., Dubuc M., et al. Efficacy of hemobahn in the treatment of superficial femoral artery lesions in patients with acute or critical ischemia. a comparative study with claudicants. Eur J Vasc Endovasc Surg 30 (2005) 300-306
38. Rosenbloom M.S., Walsh J.J., Schuler J.J., et al. Long-term results of infragenicular bypasses with autologous vein originating from the distal superficial femoral and popliteal arteries. J Vasc Surg 7 (1988) 691-696
39. Gallino A., Mahler F., Probst P., et al. Percutaneous transluminal angioplasty of the arteries of the lower limbs. a 5 year follow-up. Circulation 70 (1984) 619-623
40. Jeans W.D., Armstrong S., Cole S.E.A., et al. Fate of patients undergoing transluminal angioplasty for lower-limb ischemia 177 (1990) 559-564
41. Schweiger H., Klein P., and Lang W. Tibial bypass grafting for limb salvage with ringed polytetrafluoroethylene prostheses. results of primary and secondary procedures. J Vasc Surg 18 (1993) 867-874
42. Tielliu I.F., Verhoeven E.L., Prins T.R., et al. Treatment of popliteal artery aneurysms with the Hemobahn stent-graft. J Endovasc Ther 10 (2003) 111-116
43. Tielliu I.F., Verhoeven E.L., Zeebregts C.J., et al. Endovascular treatment of popliteal artery aneurysms. results of a prospective cohort study. J Vasc Surg 41 (2005) 561-567
44. CAPRIE steering committee. A randomized, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348 (1996) 1329-1339
45. Green R.M., Roedersheimer L.R., and DeWeese J.A. Effects of aspirin and dipyridamole on expanded polytetrafluoroethylene graft patency. Surgery 92 (1982) 1016-1026
46. Becquemin J.P. Effect of ticlopidine on the long term patency of saphenous vein bypass grafts in the legs. N Engl J Med 337 (1997) 1726-1731
47. Cohen J.R., Mannick J.A., Couch N.P., et al. Recognition and management of impending graft failure. importance for long-term patency. Arch Surg 121 (1986) 758-759
48. Lalak N.J., Hanel K.C., Hunt J., et al. Duplex-scan surveillance of infrainguinal prosthetic grafts. J Vasc Surg 20 (1994) 637-641
49. Dunlop P., Sayers R.D., Naylor A.R., et al. The effect of a surveillance program on the patency of prosthetic infrainguinal bypass grafts. Eur J Vasc Endovas Surg 11 (1996) 441-445